Galapagos | GLPG - Devedores Comerciais

Preço das Ações
24.66
Mudança Diária
0.66 2.75%
Mensal
-13.41%
Anual
16.65%
Q2 Previsão
23.83




Devedores Comerciais Alterar Data
argenx SE USD 1.2B 289.13M 2025-06
AstraZeneca USD 19.05B 1.49B 2025-12
Biogen USD 1.85B 234M 2025-09
Genmab DKK 1.17B 119M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
GRIFOLS EUR 852M 244.52M 2025-12
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Merck EUR 4.44B 293M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 100M 2025-12
UCB EUR 1.97B 54M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12